The eIF2-alpha kinase HRI: a potential target beyond the red blood cell

References

• Spilka R, Ernst C, Mehta AK, et al. Eukaryotic translation initiation factors in cancer development and progression. Cancer Lett. 2013;340(1):9–21.
   PubMed Web of Science ®Google Scholar
• Dever TE, Green R. The elongation, termination, and recycling phases of translation in eukaryotes. Cold Spring Harb Perspect Biol. 2012;4(7):a013706.
   PubMed Web of Science ®Google Scholar
• Baird TD, Wek RC. Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism. Adv Nutr. 2012;3(3):307–321.
   PubMed Web of Science ®Google Scholar
• Donnelly N, Gorman AM, Gupta S, et al. The eIF2alpha kinases: their structures and functions. Cell Mol Life Sci. 2013. DOI:10.1007/s00018-012-1252-6.
   PubMed Web of Science ®Google Scholar
• Chen JJ. Translational control by heme-regulated eIF2alpha kinase during erythropoiesis. Curr Opin Hematol. 2014;21(3):172–178.
   PubMed Web of Science ®Google Scholar
• Rajesh K, Krishnamoorthy J, Kazimierczak U, et al. Phosphorylation of the translation initiation factor eIF2alpha at serine 51 determines the cell fate decisions of Akt in response to oxidative stress. Cell Death Dis. 2015;6:e1591.
   PubMed Web of Science ®Google Scholar
• Suragani RN, Zachariah RS, Velazquez JG, et al. Heme-regulated eIF2alpha kinase activated Atf4 signaling pathway in oxidative stress and erythropoiesis. Blood. 2012;119(22):5276–5284.
   PubMed Web of Science ®Google Scholar
• Jiang HY, Wek RC. Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J Biol Chem. 2005;280(14):14189–14202.
   PubMed Web of Science ®Google Scholar
• Yerlikaya A, Kimball SR, Stanley BA. Phosphorylation of eIF2alpha in response to 26S proteasome inhibition is mediated by the haem-regulated inhibitor (HRI) kinase. Biochem J. 2008;412(3):579–588.
   PubMed Web of Science ®Google Scholar
• Zhan K, Narasimhan J, Wek RC. Differential activation of eIF2 kinases in response to cellular stresses in schizosaccharomyces pombe. Genetics. 2004;168(4):1867–1875.
   PubMed Web of Science ®Google Scholar
• Mignone F, Gissi C, Liuni S, et al. Untranslated regions of mRNAs. Genome Biol. 2002;3(3):REVIEWS0004.
   PubMed Web of Science ®Google Scholar
• Harding HP, Novoa I, Zhang Y, et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell. 2000;6(5):1099–1108.
   PubMed Web of Science ®Google Scholar
• Harding HP, Zhang Y, Zeng H, et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell. 2003;11(3):619–633.
   PubMed Web of Science ®Google Scholar
• Han AP, Yu C, Lu L, et al. Heme-regulated eIF2alpha kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency. EMBO J. 2001;20(23):6909–6918.
   PubMed Web of Science ®Google Scholar
• Wek RC, Jiang HY, Anthony TG. Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans. 2006;34(Pt 1): 7–11.
   PubMed Web of Science ®Google Scholar
• Palam LR, Baird TD, Wek RC. Phosphorylation of eIF2 facilitates ribosomal bypass of an inhibitory upstream ORF to enhance CHOP translation. J Biol Chem. 2011;286(13):10939–10949.
   PubMed Web of Science ®Google Scholar
• Novoa I, Zeng H, Harding HP, et al. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol. 2001;153(5):1011–1022.
   PubMed Web of Science ®Google Scholar
• Teske BF, Fusakio ME, Zhou D, et al. CHOP induces activating transcription factor 5 (ATF5) to trigger apoptosis in response to perturbations in protein homeostasis. Mol Biol Cell. 2013;24(15):2477–2490.
   PubMed Web of Science ®Google Scholar
• Urra H, Dufey E, Lisbona F, et al. When ER stress reaches a dead end. Biochim Biophys Acta. 2013;1833(12):3507–3517.
   PubMed Web of Science ®Google Scholar
• Pal JK, Chen JJ, London IM. Tissue distribution and immunoreactivity of heme-regulated eIF-2 alpha kinase determined by monoclonal antibodies. Biochemistry. 1991;30(9):2555–2562.
   PubMed Web of Science ®Google Scholar
• Crosby JS, Lee K, London IM, et al. Erythroid expression of the heme-regulated eIF-2 alpha kinase. Mol Cell Biol. 1994;14(6):3906–3914.
   PubMed Web of Science ®Google Scholar
• Mellor H, Flowers KM, Kimball SR, et al. Cloning and characterization of cDNA encoding rat hemin-sensitive initiation factor-2 alpha (eIF-2 alpha) kinase. evidence for multitissue expression. J Biol Chem. 1994;269(14):10201–10204.
   PubMed Web of Science ®Google Scholar
• Berlanga JJ, Herrero S, de Haro C. Characterization of the hemin-sensitive eukaryotic initiation factor 2alpha kinase from mouse nonerythroid cells. J Biol Chem. 1998;273(48):32340–32346.
   PubMed Web of Science ®Google Scholar
• Lu L, Han AP, Chen JJ. Translation initiation control by heme-regulated eukaryotic initiation factor 2alpha kinase in erythroid cells under cytoplasmic stresses. Mol Cell Biol. 2001;21(23):7971–7980.
   PubMed Web of Science ®Google Scholar
• Acharya P, Chen JJ, Correia MA. Hepatic heme-regulated inhibitor (HRI) eukaryotic initiation factor 2alpha kinase: a protagonist of heme-mediated translational control of CYP2B enzymes and a modulator of basal endoplasmic reticulum stress tone. Mol Pharmacol. 2010;77(4):575–592.
   PubMed Web of Science ®Google Scholar
• Zarei M, Barroso E, Leiva R, et al. Heme-regulated eIF2alpha kinase modulates hepatic FGF21 and is activated by PPARbeta/delta deficiency. Diabetes. 2016;65(10):3185–3199.
   PubMed Web of Science ®Google Scholar
• Jiang S, Yan C, Fang QC, et al. Fibroblast growth factor 21 is regulated by the IRE1alpha-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis. J Biol Chem. 2014;289(43):29751–29765.
   PubMed Web of Science ®Google Scholar
• Liu S, Suragani RN, Wang F, et al. The function of heme-regulated eIF2alpha kinase in murine iron homeostasis and macrophage maturation. J Clin Invest. 2007;117(11):3296–3305.
   PubMed Web of Science ®Google Scholar
• Ramos-Fernandez E, Tajes M, Ill-Raga G, et al. Glutamatergic stimulation induces GluN2B translation by the nitric oxide-heme-regulated eIF2alpha kinase in cortical neurons. Oncotarget. 2016;7(37):58876–58892.
   PubMed Web of Science ®Google Scholar
• Storey GP, Opitz-Araya X, Barria A. Molecular determinants controlling NMDA receptor synaptic incorporation. J Neurosci. 2011;31(17):6311–6316.
   PubMed Web of Science ®Google Scholar
• Ill-Raga G, Tajes M, Busquets-Garcia A, et al. Physiological control of nitric oxide in neuronal BACE1 translation by heme-regulated eIF2alpha kinase HRI induces synaptogenesis. Antioxid Redox Signal. 2015;22(15):1295–1307.
   PubMed Web of Science ®Google Scholar
• Burwick N, Zhang MY, de la Puente P, et al. The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma. Leuk Res. 2017;55:23–32.
   PubMed Web of Science ®Google Scholar
• Chen T, Ozel D, Qiao Y, et al. Chemical genetics identify eIF2alpha kinase heme-regulated inhibitor as an anticancer target. Nat Chem Biol. 2011;7(9):610–616.
   PubMed Web of Science ®Google Scholar
• Yefidoff-Freedman R, Fan J, Yan L, et al. Development of 1-((1,4-trans)-4-aryloxycyclohexyl)-3-arylurea activators of the heme regulated inhibitor as selective activators of eucaryotic translation initiation factor 2 alpha (eIF2alpha) phosphorylation arm of the integrated endoplasmic reticulum stress response. J Med Chem. 2017;60(13):5392–5406.
   PubMed Web of Science ®Google Scholar
• Donze O, Jagus R, Koromilas AE, et al. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J. 1995;14(15):3828–3834.
   PubMed Web of Science ®Google Scholar
• Lobo MV, Martin ME, Perez MI, et al. Levels, phosphorylation status and cellular localization of translational factor eIF2 in gastrointestinal carcinomas. Histochem J. 2000;32(3):139–150.
   PubMedGoogle Scholar
• Wang S, Rosenwald IB, Hutzler MJ, et al. Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-hodgkin’s lymphomas. Am J Pathol. 1999;155(1):247–255.
   PubMed Web of Science ®Google Scholar
• He Y, Correa AM, Raso MG, et al. The role of PKR/eIF2alpha signaling pathway in prognosis of non-small cell lung cancer. PLoS One. 2011;6(11):e24855.
   PubMed Web of Science ®Google Scholar
• Mounir Z, Krishnamoorthy JL, Robertson GP, et al. Tumor suppression by PTEN requires the activation of the PKR-eIF2alpha phosphorylation pathway. Sci Signal. 2009;2(102):ra85.
   PubMed Web of Science ®Google Scholar
• Oakes SA. Endoplasmic reticulum proteostasis: a key checkpoint in cancer. Am J Physiol Cell Physiol. 2017;312(2):C102.
   Web of Science ®Google Scholar
• Cubillos-Ruiz JR, Bettigole SE, Glimcher LH. Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer. Cell. 2017;168(4):692–706.
   PubMed Web of Science ®Google Scholar
• Aktas BH, Qiao Y, Ozdelen E, et al. Small-molecule targeting of translation initiation for cancer therapy. Oncotarget. 2013;4(10):1606–1617.
   PubMed Web of Science ®Google Scholar
• Chen L, Aktas BH, Wang Y, et al. Tumor suppression by small molecule inhibitors of translation initiation. Oncotarget. 2012;3(8):869–881.
   PubMed Web of Science ®Google Scholar
• Bhat M, Robichaud N, Hulea L, et al. Targeting the translation machinery in cancer. Nat Rev Drug Discov. 2015;14(4):261–278.
   PubMed Web of Science ®Google Scholar
• Benjamin D, Colombi M, Moroni C, et al. Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov. 2011;10(11):868–880.
   PubMed Web of Science ®Google Scholar
• Pal SK, Reckamp K, Yu H, et al. Akt inhibitors in clinical development for the treatment of cancer. Expert Opin Investig Drugs. 2010;19(11):1355–1366.
   PubMed Web of Science ®Google Scholar
• Lindsley CW, Zhao Z, Leister WH, et al. Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors. Bioorg Med Chem Lett. 2005;15(3):761–764.
   PubMed Web of Science ®Google Scholar
• Garg AD, Maes H, van Vliet AR, et al. Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress. Mol Cell Oncol. 2014;2(1):e975089.
   PubMedGoogle Scholar
• Schonthal AH. Pharmacological targeting of endoplasmic reticulum stress signaling in cancer. Biochem Pharmacol. 2013;85(5):653–666.
   PubMed Web of Science ®Google Scholar
• Smith AL, Andrews KL, Beckmann H, et al. Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK). J Med Chem. 2015;58(3):1426–1441.
   PubMed Web of Science ®Google Scholar
• Axten JM, Romeril SP, Shu A, et al. Discovery of GSK2656157: an optimized PERK inhibitor selected for preclinical development. ACS Med Chem Lett. 2013;4(10):964–968.
   PubMed Web of Science ®Google Scholar
• Bryk R, Wu K, Raimundo BC, et al. Identification of new inhibitors of protein kinase R guided by statistical modeling. Bioorg Med Chem Lett. 2011;21(13):4108–4114.
   PubMed Web of Science ®Google Scholar
• Chauhan D, Tian Z, Zhou B, et al. In vitro and in vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN9708 against multiple myeloma cells. Clin Cancer Res. 2011;17(16):5311–5321.
   PubMed Web of Science ®Google Scholar
• Yerlikaya A, DoKudur H. Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells. Mol Biol (Mosk). 2010;44(5):859–866.
   PubMed Web of Science ®Google Scholar
• Teng Y, Gao M, Wang J, et al. Inhibition of eIF2alpha dephosphorylation enhances TRAIL-induced apoptosis in hepatoma cells. Cell Death Dis. 2014;5:e1060.
   PubMed Web of Science ®Google Scholar
• Jeon YJ, Kim JH, Shin JI, et al. Salubrinal-mediated upregulation of eIF2alpha phosphorylation increases doxorubicin sensitivity in MCF-7/ADR cells. Mol Cells. 2016;39(2):129–135.
   PubMed Web of Science ®Google Scholar
• Schewe DM, Aguirre-Ghiso JA. Inhibition of eIF2alpha dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy. Cancer Res. 2009;69(4):1545–1552.
   PubMed Web of Science ®Google Scholar
• Obeng EA, Carlson LM, Gutman DM, et al. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood. 2006;107(12):4907–4916.
   PubMed Web of Science ®Google Scholar
• Hinnebusch AG. Translational regulation of yeast GCN4. A window on factors that control initiator-trna binding to the ribosome. J Biol Chem. 1997;272(35):21661–21664.
   PubMed Web of Science ®Google Scholar
• Aktas BH, Bordelois P, Peker S, et al. Depletion of eIF2.GTP.met-tRNAi translation initiation complex up-regulates BRCA1 expression in vitro and in vivo. Oncotarget. 2015;6(9):6902–6914.
   PubMed Web of Science ®Google Scholar
• Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol. 1991;115(4):887–903.
   PubMed Web of Science ®Google Scholar
• Chen T, Takrouri K, Hee-Hwang S, et al. Explorations of substituted urea functionality for the discovery of new activators of the heme-regulated inhibitor kinase. J Med Chem. 2013;56(23):9457–9470.
   PubMed Web of Science ®Google Scholar
• Koromilas AE, Mounir Z. Control of oncogenesis by eIF2alpha phosphorylation: implications in PTEN and PI3K-akt signaling and tumor treatment. Future Oncol. 2013;9(7):1005–1015.
   PubMed Web of Science ®Google Scholar
• Kazemi S, Mounir Z, Baltzis D, et al. A novel function of eIF2alpha kinases as inducers of the phosphoinositide-3 kinase signaling pathway. Mol Biol Cell. 2007;18(9):3635–3644.
   PubMed Web of Science ®Google Scholar
• Mounir Z, Krishnamoorthy JL, Wang S, et al. Akt determines cell fate through inhibition of the PERK-eIF2alpha phosphorylation pathway. Sci Signal. 2011;4(192):ra62.
   PubMed Web of Science ®Google Scholar
• Whitney ML, Jefferson LS, Kimball SR. ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression. Biochem Biophys Res Commun. 2009;379(2):451–455.
   PubMed Web of Science ®Google Scholar
• Saveljeva S, Cleary P, Mnich K, et al. Endoplasmic reticulum stress-mediated induction of SESTRIN 2 potentiates cell survival. Oncotarget. 2016;7(11):12254–12266.
   PubMed Web of Science ®Google Scholar
• Ye J, Palm W, Peng M, et al. GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2. Genes Dev. 2015;29(22):2331–2336.
   PubMed Web of Science ®Google Scholar
• Sendoel A, Dunn JG, Rodriguez EH, et al. Translation from unconventional 5ʹ start sites drives tumour initiation. Nature. 2017;541(7638):494–499.
   PubMed Web of Science ®Google Scholar
• Han AP, Fleming MD, Chen JJ. Heme-regulated eIF2alpha kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and beta-thalassemia. J Clin Invest. 2005;115(6):1562–1570.
   PubMed Web of Science ®Google Scholar
• Hahn CK, Lowrey CH. Eukaryotic initiation factor 2alpha phosphorylation mediates fetal hemoglobin induction through a post-transcriptional mechanism. Blood. 2013;122(4):477–485.
   PubMed Web of Science ®Google Scholar
• Manasanch EE, Orlowski RZ. Proteasome inhibitors in cancer therapy. Nat Rev Clin Oncol. 2017;14(7):417–433.
   PubMed Web of Science ®Google Scholar
• Scheper W, Hoozemans JJ. A new PERKspective on neurodegeneration. Sci Transl Med. 2013;5(206):206fs37.
   PubMed Web of Science ®Google Scholar
• Atkins C, Liu Q, Minthorn E, et al. Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res. 2013;73(6):1993–2002.
   PubMed Web of Science ®Google Scholar
• Trinh MA, Kaphzan H, Wek RC, et al. Brain-specific disruption of the eIF2alpha kinase PERK decreases ATF4 expression and impairs behavioral flexibility. Cell Rep. 2012;1(6):676–688.
   PubMed Web of Science ®Google Scholar
• Way SW, Podojil JR, Clayton BL, et al. Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic. Nat Commun. 2015;6:6532.
   PubMed Web of Science ®Google Scholar
• Das I, Krzyzosiak A, Schneider K, et al. Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit. Science. 2015;348(6231):239–242.
   PubMed Web of Science ®Google Scholar